Glutathione S-Transferases (GSTs) Inhibit Transcriptional Activation by the Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Ligand, 15-Deoxy-Δ12,14Prostaglandin J2 (15-d-PGJ 2)

Biochemistry

Volumn 43, Issue 8, 2004, Pages 2345-2352

  Paumi, Christian M ^a   Smitherman, Pamela K ^a   Townsend, Alan J ^a   Morrow, Charles S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; ENZYME KINETICS; GENES; MASS SPECTROMETRY; METABOLITES; PROTEINS;

BIOLOGICAL ACTIVITIES; CELLULAR PROCESSES;

BIOCHEMISTRY;

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CYCLOPENTANONE DERIVATIVE; GLUTATHIONE TRANSFERASE; ISOENZYME; LIGAND; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CATALYSIS; CELL DIFFERENTIATION; CELL GROWTH; CYTOSOL; CYTOTOXICITY; DRUG ACTIVITY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME BINDING; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSACTIVATION;

CATALYSIS; CELL DEATH; CELL LINE, TUMOR; GENETIC VECTORS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GROWTH INHIBITORS; HUMANS; ISOENZYMES; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

ANIMALIA;

EID: 1442300929     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035936+     Document Type: Article

References (43)

1. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell 83, 813-819.
2. Atsmon, J., Freeman, M., Meredith, M., Sweetman, B., and Roberts, L., 2d. (1990) Conjugation of 9-deoxy-delta 9,delta 12-(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion, Cancer Res. 50, 1879-1885.
3. Honn, K. V., and Marnett, L. J. (1985) Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins, Biochem. Biophys. Res. Commun. 129, 34-40.
4. Clay, C. E., Namen, A. M., Fonteh, A. N., Atsumi, G., High, K. P., and Chilton, F. H. (2000) 15-deoxy-[Delta]12,14PGJ2 induces diverse biological responses via PPAR[gamma] activation in cancer cells, Prostaglandins Other Lipid Mediators 62, 23-32.
5. Clay, C. E., Namen, A. M., Atsumi, G.-i., Willingham, M. C., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A., and Chilton, F. H. (1999) Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells, Carcinogenesis 20, 1905-1911.
6. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell, 83, 803-812.
7. 2 regulates mesangial cell proliferation and death, Kidney Int. 61, 1293-1302.
8. Dussault, I., and Forman, B. M. (2000) Prostaglandins and fatty acids regulate transcriptional signaling via the peroxisome proliferator activated receptor nuclear receptors, Prostaglandins Other Lipid Mediators 62, 1-13.
9. Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., and Uchida, K. (2002) 15-Deoxy-Delta 12,14-prostaglandin J2. A prostaglandin d2 metabolite generated during inflammatory processes, J. Biol. Chem. 277, 10459-10466.
10. Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., and Glass, C. K. (2000) 15-Deoxy-Delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway, Proc. Natl. Acad. Sci. U.S.A. 97, 4844-4849.
11. Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., and Santoro, M. G. (2000) Antiinflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase, Nature 403, 103-108.
12. Oliva, J. L., Perez-Sala, D., Castrillo, A., Martinez, N., Canada, F. J., Bosca, L., and Rojas, J. M. (2003) The cyclopentenone 15-deoxy-Delta 12,14-prostaglandin J2 binds to and activates H-Ras, Proc. Natl. Acad. Sci. U.S.A. 100, 4772-4777.
13. Castrillo, A., Diaz-Guerra, M. J., Hortelano, S., Martin-Sanz, P., and Bosca, L. (2000) Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages, Mol. Cell Biol. 20, 1692-1698.
14. Cernuda-Morollon, E., Pineda-Molina, E., Canada, F. J., and Perez-Sala, D. (2001) 15-Deoxy-Delta 12,14-prostaglandin J2 Inhibition of NF-kappa B-DNA Binding through Covalent Modification of the p50 Subunit, J. Biol. Chem., 276, 35530-35536.
15. 12(E)-prostaglandin D2, Biochemistry 29, 3760-3765.
16. 12,14Prostaglandin J(2) in MCF7 Breast Cancer Cells, Biochemistry 42, 5429-5437.
17. Bogaards, J. J., Venekamp, J. C., and van Bladeren, P. J. (1997) Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1, Chem. Res. Toxicol. 10, 310-317.
18. Kodera, Y., Takeyama, K., Murayama, A., Suzawa, M., Masuhiro, Y., and Kato, S. (2000) Ligand type-specific interactions of peroxisomal proliferator-activated receptor γ with transcriptional coactivators, J. Biol. Chem. 43, 33201-33204.
19. Chawla, A., Repa, J. J., Evans, R. M., and Mangelsdorf, D. J. (2001) Nuclear Receptors and Lipid Physiology: Opening the X-Files, Science 294, 1866-1870.
20. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., and Wahli, W. (1997) Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand Assay, Mol Endocrinol. 11, 779-791.
21. Hihi, A. K., Michalik, L., and Wahli, W. (2002) PPARs: transcriptional effectors of fatty acids and their derivatives, Cell. Mol. Life Sci. 59, 790-798.
22. Shimada, T., Kojima, K., Yoshiura, K., Hiraishi, H., and Terano, A. (2002) Characteristics of the peroxisome proliferator activated receptor {gamma} (PPAR{gamma}) ligand induced apoptosis in colon cancer cells, Gut 50, 658-664.
23. Padilla, J., Leung, E., and Phipps, R. P. (2002) Human B Lymphocytes and B Lymphomas Express PPAR-[gamma] and Are Killed by PPAR-[gamma] Agonists, Clin. Immunol. 103, 22-33.
24. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., and Koeffler, H. P. (1998) Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice, Proc. Natl. Acad. Sci. U.S.A. 95, 8806-8811.
25. Smitherman, P. K., Townsend, A. J., Kute, T. E., and Morrow, C. S. (2003) Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity, J. Pharmacol. Exp. Ther. jpet. 103.057729.
26. DeJong, J. L., Chang, C.-M., Whang-Peng, J., Knudsen, T., and Tu, C.-P. D. (1988) The human glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA, Nucleic Acids Res. 16, 8541-8554.
27. Tu, C.-P. D., and Qian, B. (1986) Human liver glutathione S-transferases: complete primary sequence of a Ha subunit, Biochem. Biophys. Res. Commun. 141, 229-237.
28. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S., O'Brien, E. E., Poplack, D. G., Cossman, J., Myers, C. E., and Cowan, K. H. (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors, Cancer Res. 49, 1422-1428.
29. Miller, A. D., Miller, D. G., Garcia, J. V., and Lynch, C. M. (1993) Use of retroviral vectors for gene transfer and expression, Methods Enzymol. 217, 581-599.
30. Morrow, C. S., Smitherman, P. K., Diah, S. K., Schneider, E., and Townsend, A. J. (1998) Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells, J. Biol. Chem. 273, 20114-20120.
31. Hipfner, D. R., Gauldie, S. D., Deeley, R. G., and Cole, S. P. C. (1994) Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies, Cancer Res. 54, 5788-5792.
32. Habig, W., Pabst, M., and Jakoby, W. (1974) Glutathione S-transferase: the first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249, 7130-7139.
33. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82, 1107-1112.
34. Parsonage, D., Miller, H., Ross, R., and Claiborne, A. (1993) Purification and analysis of streptococcal NADH peroxidase expressed in Escherichia coli, J. Biol. Chem. 268, 3161-3167.
35. Paumi, C. M., Ledford, B. G., Smitherman, P. K., Townsend, A. J., and Morrow, C. S. (2001) Role of Multidrug Resistance Protein 1 (MRP1) and Glutathione S-Transferase A1-1 in Alkylating Agent Resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity, J. Biol. Chem. 276, 7952-7956.
36. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254.
37. Habig, W. H., Pabst, M. J., Fleischner, G., Gatmaitan, Z., Arias, I. M., and Jakoby, W. B. (1974) The identity of glutathione S-transferase B with ligandin, a major binding protein of liver, Proc. Natl. Acad. Sci. U.S.A. 71, 3879-3882.
38. Ketley, J. N., Habig, W. H., and Jakoby, W. B. (1975) Binding of nonsubstrate ligands to the glutathione S-transferases, J. Biol. Chem. 250, 8670-8673.
39. Nishihira, J., Ishibashi, T., Sakai, M., Tsuda, S., and Hikichi, K. (1993) Identification of the hydrophobic ligand-binding region in recombinant glutathione S-transferase P and its binding effect on the conformational state of the enzyme, Arch. Biochem. Biophys. 302, 128-133.
40. Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., and Milburn, M. V. (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma, Nature 395, 137-143.
41. Ferry, G., Bruneau, V., Beauverger, P., Goussard, M., Rodriguez, M., Lamamy, V., Dromaint, S., Canet, E., Galizzi, J., and Boutin, J. A. (2001) Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands, Eur. J. Pharmacol. 417, 77-89.
42. Clay, C. E., Monjazeb, A., Thorburn, J., Chilton, F. H., and High, K. P. (2002) 15-Deoxy-{Delta}12,14-prostaglandin J2-induced apoptosis does not require PPAR{gamma} in breast cancer cells. J. Lipid Res. 43, 1818-1828.
43. Perez-Sala, D., Cernuda-Morollon, E., Pineda-Molina, E., and Canada, F. J. (2002) Contribution of Covalent Protein Modification to the Antiinflammatory Effects of Cyclopentenone Prostaglandins. Ann. N. Y. Acad. Sci. 973, 533-536.